Modes and duration
- Full-time: 1 year
Tuition Fees (2015/16)
- £9,835 (FT)
- £23,690 (FT)
- All applicants:
- 31 July 2015
A medical degree or a minimum of an upper second-class UK Bachelor’s degree in neuroscience, biomedical science, psychology or a related science discipline or an overseas qualification of an equivalent standard. Applicants with a degree in another area, or experience in life sciences or pharmacology will be considered on an individual basis.
English Language Requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Good
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
The student will study the entire process of translating basic neuroscience discoveries into diagnostic and therapeutic applications. The programme focuses mostly (but not exclusively) on the visual process. Students will study the theoretical framework specific to translation, and have the opportunity to explore the entire field (molecular cell biology, pharmacology, and psychophysics), gaining hands-on experience in an original research project.
Students undertake modules to the value of 180 credits.
The programme consists of five core modules (75 credits), three optional modules (45 credits) and a dissertation/report (60 credits).
- Developing Translational Research
- Masterclasses in Translational and Regenerative Neuroscience
- Ocular Cell Biology
- Research in Practice
- Translating Science into the Clinic
- Cost Benefit Analysis and Health
- Genetics and Epidemiology of Ocular Disease
- Introduction to Visual Neuroscience
- Microvascular Biology
- Modern Aspects of Drug Discovery
- Ocular Development in Health and Disease
- Pharmacogenomics, Adverse Drug Reactions and Biomarkers
All students will undertake an independent research project which culminates in a dissertation of 10,000–12,000 words and an oral presentation.
Teaching and Learning
The programme is delivered through a combination of lectures, seminars and student group presentations. Assessment is through a mixture of unseen exams, coursework (essays, bioinformatic tasks, practicals), a major dissertation, and oral presentations.
Scholarships relevant to this department are displayed below. For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
The first cohort of students on the Translational and Regenerative Neuroscience MSc are due to graduate in 2015, therefore no informaton on graduate destinations is currently available.
However, the UCL Institute of Ophthalmology has been making headway against blindness and there is an anticipated need for highly trained generations of scientists to capitalise on these advances in the future.
Studying the fundamental methods underlying translational research will give students a deep understanding that is highly transferable to translational therapies in other organs. Participating in this programme is likely to prove highly valuable for those science graduates considering working in industry, clinical trials administration, and for regulatory bodies such as NICE, as well as for anyone wishing to pursue an academic research career in translational research.
Why study this degree at UCL?
UCL offers unique opportunities to study translational and regenerative neuroscience. UCL is the largest centre for biomedical research in the UK, and the Faculty of Brain Sciences contains the UK’s largest concentration of neuroscientists. The UCL Institute of Ophthalmology is an international leader in translational research, with a broad range of innovative therapies being developed in many different modalities, from genes to machines.
The eye offers a unique site for novel and highly experimental therapies, particularly in neuroscience. Approaches to repair defective vision include replacement of either genes or cells, and major advances in both these fields have been made by academics at the UCL Institute of Ophthalmology.
The programme will include input from other departments in the faculty, including the UCL Institute of Neurology, and the UCL Ear Institute. There will be major opportunities for networking with academics and industry specialists teaching on the programme.
Student / staff ratios › 77 staff › 57 taught students › 112 research students
Department: Institute of Ophthalmology
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
The programme is best suited to people looking to further a career in translational neuroscience research, either in academia or in a pharmaceutical setting. Alternatively, the programme will be very useful for people looking to move into related areas such as research regulation and management.
- All applicants
- 31 July 2015
For more information see our Applications page.Apply now
What are we looking for?When we assess your application we would like to learn:
- why you want to study Translational and Regenerative Neuroscience at graduate level
- why you want to study Translational and Regenerative Neuroscience at UCL
- what particularly attracts you to this programme
- how your personal, academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree